Trials / Sponsors / GW Research Ltd
GW Research Ltd
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome | Phase 3 | 2015-06-11 |
| Completed | A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160) Ulcerative Colitis | Phase 2 | 2012-05-09 |
| Terminated | Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine Schizophrenia | Phase 2 | 2011-10-01 |
| Completed | Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease Fatty Liver | Phase 2 | 2011-05-03 |
| Withdrawn | Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an a Spasticity, Multiple Sclerosis | Phase 3 | — |